Pro Share Advisors LLC Akero Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,309 shares of AKRO stock, worth $929,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,309

Previous 19,729 12.27%

Holding current value

$929,493

Previous $798,000 15.66%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$34.04 - $56.28 $82,376 - $136,197	-2,420 Reduced 12.27%	17,309 $923,000
Q1 2025 May 08, 2025	SELL	$21.87 - $57.56 $58,371 - $153,627	-2,669 Reduced 11.92%	19,729 $798,000
Q4 2024 Feb 13, 2025	BUY	$26.75 - $35.28 $146,509 - $193,228	5,477 Added 32.37%	22,398 $623,000
Q3 2024 Nov 13, 2024	BUY	$21.45 - $29.34 $94,594 - $129,389	4,410 Added 35.25%	16,921 $485,000
Q2 2024 Aug 13, 2024	SELL	$18.31 - $24.62 $45,591 - $61,303	-2,490 Reduced 16.6%	12,511 $293,000
Q1 2024 May 08, 2024	BUY	$17.76 - $31.18 $52,303 - $91,825	2,945 Added 24.43%	15,001 $378,000
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $19,949 - $88,228	1,753 Added 17.01%	12,056 $281,000
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $36,247 - $45,980	880 Added 9.34%	10,303 $521,000
Q2 2023 Aug 10, 2023	BUY	$36.89 - $56.88 $76,657 - $118,196	2,078 Added 28.29%	9,423 $439,000
Q1 2023 May 11, 2023	SELL	$37.27 - $50.24 $37,568 - $50,641	-1,008 Reduced 12.07%	7,345 $281,000
Q4 2022 Feb 02, 2023	BUY	$33.44 - $54.8 $70,357 - $115,299	2,104 Added 33.67%	8,353 $457,000
Q3 2022 Nov 04, 2022	BUY	$10.15 - $34.05 $63,427 - $212,778	6,249 New	6,249 $213,000
Q1 2022 May 10, 2022	SELL	$12.97 - $22.26 $136,561 - $234,375	-10,529 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$19.87 - $26.24 $4,192 - $5,536	-211 Reduced 1.96%	10,529 $223,000
Q3 2021 Nov 12, 2021	SELL	$18.65 - $25.46 $40,824 - $55,731	-2,189 Reduced 16.93%	10,740 $240,000
Q2 2021 Aug 13, 2021	BUY	$24.81 - $32.35 $111,793 - $145,769	4,506 Added 53.5%	12,929 $321,000
Q1 2021 May 14, 2021	BUY	$24.04 - $34.19 $1,514 - $2,153	63 Added 0.75%	8,423 $244,000
Q4 2020 Feb 09, 2021	BUY	$25.12 - $29.89 $27,883 - $33,177	1,110 Added 15.31%	8,360 $216,000
Q3 2020 Nov 13, 2020	BUY	$30.79 - $39.92 $223,227 - $289,420	7,250 New	7,250 $223,000

Others Institutions Holding AKRO

# of Institutions

297

Shares Held

92.2M

Call Options Held

1.72M

Put Options Held

901K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.49B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Akero Therapeutics, Inc. Transaction History